Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units
- Conditions
- Alzheimer Disease
- Interventions
- Behavioral: patients with alzheimer's disease
- Registration Number
- NCT01901263
- Brief Summary
Cognitive and behavioral units (CBUs) have been created between 2008 and 2012 French National Alzheimer plan for the management of behavior problems of patients suffering from Alzheimer's disease or other related disorders and necessitating hospitalisation. This Alzheimer plan is promoting the evaluation of these units through the observation of the behavioral and psychological symptoms of dementia (BPSD) evolution. As these units are new, it appears important to assess their long-term impact on patients care.
- Detailed Description
EXPECTED RESULTS The present study should allow to better understand the long-term impact of CBU on care of patients with Alzheimer disease and BPSD. Moreover, it should allow to identify patients improved by CBU.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 306
- patient hospitalized on CBUs
- patient with the diagnostic criteria for disease related to dementia stage with a Clinical Demential Rating β₯ 1
- patient with a caregiver who is fairly frequent contact with the patient in order to observe the appearance of behavior changes
- Patient living alone at home
- Patient with risk of death within one year
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patient with alzheimer's disease patients with alzheimer's disease Cohort of patients with psychological symptoms of dementia hospitalised in Cognitive and Behaviorial Units (CBUs) Evaluation of these units through the observation of the behavioral and psychological symptoms of dementia evolution : NPI score, caregivers quality of life, caregivers burden, collection of psychotropic drugs, the rehospitalisation rate
- Primary Outcome Measures
Name Time Method Neuropsychiatric Inventory (NPI) score one year impact of CBU effectiveness in reducing BPSD
- Secondary Outcome Measures
Name Time Method Psychotropic drugs (in particular neuroleptic drugs) consumption one year rehospitalisation rate for BPSD of the patients in the year following their hospitalisation in CBU one year CBU effectiveness in reducing BPSD 6 months CBU effectiveness on quality of life of patients and caregivers, and on caregivers' burden one year
Trial Locations
- Locations (3)
Hospices Civils de Lyon
π«π·Villeurbanne, France
CHU de Saint Etienne
π«π·Saint Etienne, France
CH Saint Jean de Dieu
π«π·Lyon, France